1887

Abstract

SUMMARY

Fungi isolated from mouthrinse specimens during episodes of acute pseudomembranous fungal stomatitis and deep-seated mycoses in patients with haematological malignancies were tested for susceptibility to seven antifungal agents. Topical treatment of stomatitis with clotrimazole or chlorhexidine did not induce any change in the susceptibility of oral . Treatment of deeper mycoses with 5-fluorocytosine, however, resulted in a significant increase in oral strains resistant to this agent. Of strains isolated, 7% were resistant to 5-fluorocytosine <32 μg/ml. One patient died of disseminated mycosis during treatment with this drug; the resistant was isolated from the mouth, liver, spleen and kidneys. Strains of and resistant to 5-fluorocytosine were also found in some patients. Organisms resistant to 5-fluorocytosine were generally sensitive to polyenes and imidazoles.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-18-2-249
1984-10-01
2022-08-11
Loading full text...

Full text loading...

/deliver/fulltext/jmm/18/2/medmicro-18-2-249.html?itemId=/content/journal/jmm/10.1099/00222615-18-2-249&mimeType=html&fmt=ahah

References

  1. Auger P., Dumas C., Joly J. 1979; A study of 666 strains of Candida albicans: Correlation between serotype and susceptibility to 5-fluorocytosine. Journal of Infectious Diseases 139:590–594
    [Google Scholar]
  2. Cannell J. S. 1981; The use of antimicrobials in the mouth. Journal of International Medical Research 9:277–282
    [Google Scholar]
  3. Casals J. B. 1979; Tablet sensitivity testing of pathogenic fungi. Journal of Clinical Pathology 32:719–722
    [Google Scholar]
  4. Defever K. S., Whelan W. L., Rogers A. L., Beneke E. S., Veselenak J. M., Soli D. R. 1982; Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Antimicrobial Agents and Chemotherapy 22:810–815
    [Google Scholar]
  5. Dermoumi H. 1982; Antimykotika-Empfindlichkeit bei klinisch bedeutsamen Hefen und Schimmelpilzen im Hemmhoftest. Mykosen 25:109–117 (in German)
    [Google Scholar]
  6. Hamilton-Miller J. M. T. 1972; A comparative in vitro study of amphotericin B. clotrimazole and 5-fluorocytosine against clinically isolated yeasts. Sabouraudia 10:276–283
    [Google Scholar]
  7. Hoeprich P. D., Ingraham J. L., Kleker E., Winship M. J. 1974; Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. Journal of Infectious Diseases 130:112–118
    [Google Scholar]
  8. Holt R. J. 1975; Laboratory tests of antifungal drugs. Journal of Clinical Pathology 28:767–774
    [Google Scholar]
  9. Hotchi M., Okada M., Nasu T. 1980; Present state of fungal infections in autopsy cases in Japan. A statistical survey of all autopsy cases during the ten-year period from 1966 to 1975. American Journal of Clinical Pathology 74:410–416
    [Google Scholar]
  10. Kahanpää A. 1972; Bronchopulmonary occurrence of fungi in adults especially according to cultivation material. Acta Pathologica Microbiologica Scandinavica (B) Suppl 227:1–147
    [Google Scholar]
  11. Kostiala I. 1984; C-reactive protein response induced by fungal infections. Journal of Infection 8:212–220
    [Google Scholar]
  12. Kostiala I., Kostiala A. A. I., Elonen E., Valtonen V. V., Vuopio P. 1982a; Comparison of clotrimazole and chlorhexidine in the topical treatment of acute fungal stomatitis in patients with hematological malignancies. Current Therapeutic Research 31:752–762
    [Google Scholar]
  13. Kostiala I., Kostiala A. A. I., Kahanpaa A., Elonen E. 1982b; Acute fungal stomatitis in patients with hematologic malignancies: quantity and species of fungi. Journal of Infectious Diseases 146:101
    [Google Scholar]
  14. Milne L. J. R. 1974; Mycological studies in the use of clotrimazole in bronchopulmonary aspergillosis and neonatal and vaginal candidiasis. Postgraduate Medical Journal 50: Suppl 1 20–23
    [Google Scholar]
  15. Shadomy S. 1969; In vitro studies with 5-fluorocytosine. Applied Microbiology 17:871–877
    [Google Scholar]
  16. Speller D. C. E. 1979; Antifungal agents. The Practitioner 223:511–515
    [Google Scholar]
  17. Stahel R. A., Vogt P., Schuler G., Ruttner J. R., Frick P., Oelz O. 1982; Systemic fungal infections in haematological malignancies: a growing problem. Journal of Infection 5:269–275
    [Google Scholar]
  18. Stiller R. L., Bennett J. E., Scholer H. J., Wall M., Polak A., Stevens D. A. 1982; Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrobial Agents and Chemotherapy 22:482–487
    [Google Scholar]
  19. Stiller R. L., Bennett J. E., Scholer H. J., Wall M., Polak A., Stevens D. A. 1983; Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. Journal of Infectious Diseases 147:1070–1077
    [Google Scholar]
  20. Whelan W. L., Beneke E. S., Rogers A. L., Soli D. R. 1981; Segregation of 5-fluorocytosine-resistant variants by Candida albicans . Antimicrobial Agents and Chemotherapy 19:1078–1081
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-18-2-249
Loading
/content/journal/jmm/10.1099/00222615-18-2-249
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error